CVRx (CVRX) Total Non-Current Liabilities (2020 - 2026)
CVRx's (CVRX) quarterly Total Non-Current Liabilities came in at $68.5 million in Q1 2026, up 16.84% year-on-year from $58.6 million in Q1 2025, and up 7.96% quarter-over-quarter from $63.5 million in Q4 2025.
CVRx (CVRX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
CVRx's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $68.5 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 16.84% year-over-year to $68.5 million in Q1 2026; TTM through Mar 2026 was $68.5 million, a 16.84% increase from a year earlier, with the FY2025 full-year figure at $63.5 million, up 4.2% from the prior year.
- Total Non-Current Liabilities rose to $68.5 million in Q1 2026 per CVRX's latest filing, from $63.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $68.5 million in Q1 2026 and bottomed at $6.2 million in Q2 2022.
- The 5-year median for Total Non-Current Liabilities is $38.8 million (2024), against an average of $38.5 million.
- Across the five-year window, Total Non-Current Liabilities slumped 85.72% in 2022 and soared 291.69% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $15.0 million in 2022, then soared by 155.79% to $38.2 million in 2023, then surged by 59.26% to $60.9 million in 2024, then climbed by 4.2% to $63.5 million in 2025, then rose by 7.96% to $68.5 million in 2026.
- Per Business Quant, the three latest CVRX Total Non-Current Liabilities figures stand at $68.5 million (Q1 2026), $63.5 million (Q4 2025), and $61.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | 68.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.52 Mn |
| Dec 31, 2025 | 63.47 Mn |
| Sep 30, 2025 | 61.40 Mn |
| Jun 30, 2025 | 59.90 Mn |
| Mar 31, 2025 | 58.64 Mn |
| Dec 31, 2024 | 60.91 Mn |
| Sep 30, 2024 | 61.11 Mn |
| Jun 30, 2024 | 39.47 Mn |
| Mar 31, 2024 | 38.76 Mn |
| Dec 31, 2023 | 38.25 Mn |
| Sep 30, 2023 | 22.62 Mn |
| Jun 30, 2023 | 24.12 Mn |
| Mar 31, 2023 | 22.23 Mn |
| Dec 31, 2022 | 14.95 Mn |
| Sep 30, 2022 | 7.57 Mn |
| Jun 30, 2022 | 6.16 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 5.91 Mn |
| Sep 30, 2021 | 25.00 Mn |
| Jun 30, 2021 | 43.13 Mn |